<--- Back to Details
First PageDocument Content
Chemistry / Pharmacology / Drug discovery / Computational chemistry / Clinical research / Cheminformatics / Quantitative structure–activity relationship / Drug design / Structure–activity relationship / Pharmaceutical sciences / Science / Medicinal chemistry
Date: 2012-05-07 10:12:46
Chemistry
Pharmacology
Drug discovery
Computational chemistry
Clinical research
Cheminformatics
Quantitative structure–activity relationship
Drug design
Structure–activity relationship
Pharmaceutical sciences
Science
Medicinal chemistry

Microsoft PowerPoint - 5 -InformTechnol - Richard.ppt

Add to Reading List

Source URL: www.epa.gov

Download Document from Source Website

File Size: 1,72 MB

Share Document on Facebook

Similar Documents

ED/MD ED/MD is one of NBD’s core structure-based drug design technologies. It has been developed in one of the most highly reputed simulation groups in Europe (M. Orozco group, Institute of Research in Biomedicine, Bar

DocID: 1vpEv - View Document

Metody dokowania ligandów Strategie projektowania leków Ligand-based drug design nieznana

DocID: 1vpuL - View Document

Int. J. Computational Biology and Drug Design, Vol. 2, No. 4, 2009 A novel swarm intelligence algorithm for finding DNA motifs Chengwei Lei and Jianhua Ruan* Department of Computer Science,

DocID: 1v6tg - View Document

Send Orders of Reprints at 614 Current Pharmaceutical Design, 2013, 19, Rejuvenating Sirtuins: The Rise of a New Family of Cancer Drug Targets

DocID: 1v1vA - View Document

The University of Siena is pleased to announce the 11th European Workshop in Drug Design and Mu.Ta.Lig. Training School A unique opportunity to learn and share knowledge about computational techniques in an exciting a

DocID: 1uQlo - View Document